Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Stoten will be taking over from retiring Managing Director Linda Naylor from April.

Oxford University Innovation (OUI), the research commercialisation company of Oxford University, has named its new Chief Operating Officer (COO). Dr Adam Stoten, the current Head of Technology Transfer Life Sciences at OUI, will be taking up the newly-created position from 1st April 2017.

Stoten, who holds a PhD in Immunology from the University of Nottingham, has been a leading figure at OUI since 2005 when he joined the company as a Project Manager. In 2010, he joined the Oxford-Emergent Tuberculosis Consortium, a joint venture between Oxford University and Emergent BioSolutions, which conducted the first ever efficacy study of a new tuberculosis vaccine in infants. He remained with the spinout until 2013 as its Deputy General Manager, before returning to OUI to head up its life sciences commercialisation activities.

Read more (Oxford University Innovation website)

Similar stories

AIMday in Women's Health - registration for academics now open

Events Innovation

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.

Oxford awarded major funding to probe childhood poverty and social inequalities

Awards and Appointments General Research

Ground-breaking multi-disciplinary research is to be launched today by the University of Oxford into the impact of poverty and social inequalities in early childhood, thanks to major funding from the Leverhulme Trust.

Innovation award for Professor Anindita Roy to develop new treatments for childhood cancer

Awards and Appointments General Innovation Research

Associate Professor Andi Roy leads one of the five research teams across the UK that have been awarded the 2021 Cancer Research UK-Children with Cancer UK Innovation Award. The awards, which provide a total of £4.3 million in scientific funding, will allow leading researchers in the field to delve into the biology of children’s and young people’s cancers, with the hope of finding new ways to prevent and treat these complex cancers.

Two Oxford pioneers honoured on Sherrington Building Plaques

Awards and Appointments General

Honouring the heritage of pioneering physiologists Sir Charles Sherrington and Florence Buchanan. "Commemorating both pioneers together highlights the importance of advocacy and mentoring that was evident over a century ago as equality was championed." (Professor David Paterson, Head of Department, Department of Physiology, Anatomy & Genetics)

Professor Cecilia Lindgren appointed Director of the Big Data Institute

Awards and Appointments General

Professor Cecilia Lindgren has been appointed as the new Director of the University of Oxford’s Big Data Institute.

Oxford medical researchers named NIHR Senior Investigators

Awards and Appointments General

Five leading healthcare academics in Oxford have been named National Institute of Health Research (NIHR) Senior Investigators